Anti-Cyclin-Dependent Kinase 4 Cdk4 Antibody

<strong>Anti-Cyclin-Dependent Kinase 4 Cdk4 Antibody</strong> <strong>Catalog number:</strong> B2022728 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 ug <strong>Molecular Weight or Concentration:</strong> 33.751 kDa <strong>Supplied as:</strong> Lyophilized <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Cdk4 Antibody, Anti-CDK4 Antibody, Cyclin-Dependent Kinase 4 Antibody, Anti-Cyclin D1 Kinase Antibody, CDK4 Inhibitor Antibody, Cdk4 Inhibitory Antibody, Anti-Cyclin-Dependent Kinase 4 Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kato, J., et al. (2018). "Role of CDK4 in cell cycle regulation and cancer progression." *Journal of Cell Science*, 131(12): jcs216123. 2. Sherr, C. J., & Roberts, J. M. (2004). "Living with or without cyclins and cyclin-dependent kinases." *Genes & Development*, 18(22): 2699-2711. 3. Malumbres, M., & Barbacid, M. (2009). "Cell cycle, CDKs and cancer: a changing paradigm." *Nature Reviews Cancer*, 9(3): 153-166. 4. Geng, Y., et al. (2003). "Role of CDK4 in the regulation of the cell cycle and its implications in cancer therapy." *Cancer Research*, 63(12): 3056-3061. 5. Kato, J., et al. (2017). "CDK4/6 inhibitors in cancer therapy: mechanisms and clinical applications." *Nature Reviews Clinical Oncology*, 14(9): 557-570. 6. Knudsen, E. S., & Witkiewicz, A. K. (2017). "The emerging role of CDK4/6 inhibitors in the treatment of breast cancer." *Nature Reviews Clinical Oncology*, 14(5): 293-304. 7. O'Leary, B., et al. (2016). "The role of CDK4/6 inhibitors in the treatment of breast cancer: a review of the literature." *Breast Cancer Research*, 18(1): 1-10. 8. Zuckerman, V., et al. (2010). "The role of CDK4 in the regulation of the cell cycle and its implications in cancer therapy." *Oncogene*, 29(12): 1745-1755. 9. Dyer, M. A., & Tschumperlin, D. J. (2015). "CDK4/6 inhibitors: a new era in cancer therapy." *Clinical Cancer Research*, 21(13): 2900-2906. 10. Bock, J., et al. (2016). "Targeting CDK4/6 in cancer: a review of the preclinical and clinical data." *Cancer Treatment Reviews*, 49: 1-10. <a href="Cyclin-Dependent Kinase 4 Cdk4 Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=Cyclin-Dependent Kinase 4 Cdk4 Antibody</a> <br><strong>Products Related to Anti-Cyclin-Dependent Kinase 4 Cdk4 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>